Comparison of coronary heart disease risk among four diagnostic definitions of metabolic syndrome

Journal of Endocrinological Investigation

Volumn 39, Issue 11, 2016, Pages 1337-1346

  Suzuki, T ^a,b   Zeng, Z ^c   Zhao, B ^d   Wei, Z ^e   Tanabe, M ^f   Shimbo, T ^a   Kajio, H ^a   Kato, N ^a   Naruse, M ^g  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^d Taiyuan Center for Disease Control and Prevention   (China)

^e Department of Neurology Taiyuan People s Hospital   (China)

^f FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

China; Framingham risk score; International Diabetes Federation (IDF); Japan; Metabolic syndrome; NCEP ATP III

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; CHINA; COMPLICATION; CORONARY DISEASE; MIDDLE AGED; PREVALENCE; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CHINA; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84991646690     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-016-0538-1     Document Type: Article

References (37)

1. Grundy SM (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28(4):629–636. doi:10.1161/ATVBAHA.107.151092
2. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56(14):1113–1132. doi:10.1016/j.jacc.2010.05.034
3. Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Rahman M, Arima H, Tsuryuya K, Iida M, Kiyohara Y (2007) Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study. Stroke 38(7):2063–2069. doi:10.1161/STROKEAHA.106.479642
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285(19):2486–2497
5. Society CD [Diagnostic criteria of metabolic syndrome by China Diabetes Society]. http://www.diab.net.cn/upload/11daixie.pdf
6. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J (2005) The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12(6):295–300
7. The Examination Committee for Criteria of Metabolic Syndrome (2005) Definition and the diagnostic standard for metabolic syndrome–committee to evaluate diagnostic standards for metabolic syndrome. Nihon Naika Gakkai Zasshi 94(4):794–809
8. Balkau B, Deanfield JE, Despres JP, Bassand JP, Fox KA, Smith SC Jr, Barter P, Tan CE, Van Gaal L, Wittchen HU, Massien C, Haffner SM (2007) International day for the evaluation of abdominal obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 116(17):1942–1951. doi:10.1161/CIRCULATIONAHA.106.676379
9. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome–a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23(5):469–480. doi:10.1111/j.1464-5491.2006.01858.x
10. Tan CE, Ma S, Wai D, Chew SK, Tai ES (2004) Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27(5):1182–1186
11. New criteria for ‘obesity disease’ in Japan (2002). Circ J 66 (11):987–992
12. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, Whelton PK, He J (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365(9468):1398–1405. doi:10.1016/S0140-6736(05)66375-1
13. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106(25):3143–3421
14. Hoang KC, Ghandehari H, Lopez VA, Barboza MG, Wong ND (2008) Global coronary heart disease risk assessment of individuals with the metabolic syndrome in the U.S. Diabetes Care 31(7):1405–1409. doi:10.2337/dc07-2087
15. Wildman RP, McGinn AP, Lin J, Wang D, Muntner P, Cohen HW, Reynolds K, Fonseca V, Sowers MR (2011) Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities. Obesity (Silver Spring) 19(4):853–860. doi:10.1038/oby.2010.168
16. Mancia G, Bombelli M, Facchetti R, Casati A, Ronchi I, Quarti-Trevano F, Arenare F, Grassi G, Sega R (2010) Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events. J Hypertens 28(5):999–1006. doi:10.1097/HJH.0b013e328337a9e3
17. Assmann G, Guerra R, Fox G, Cullen P, Schulte H, Willett D, Grundy SM (2007) Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol 99(4):541–548. doi:10.1016/j.amjcard.2006.08.045
18. Cui R, Iso H, Toyoshima H, Date C, Yamamoto A, Kikuchi S, Kondo T, Watanabe Y, Koizumi A, Wada Y, Inaba Y, Tamakoshi A (2005) Body mass index and mortality from cardiovascular disease among Japanese men and women: the JACC study. Stroke 36(7):1377–1382. doi:10.1161/01.STR.0000169925.57251.4e
19. Kadota A, Hozawa A, Okamura T, Kadowak T, Nakmaura K, Murakami Y, Hayakawa T, Kita Y, Okayama A, Nakamura Y, Kashiwagi A, Ueshima H (2007) Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990–2000. Diabetes Care 30(6):1533–1538. doi:10.2337/dc06-2074
20. Takahashi M, Shimomura K, Proks P, Craig TJ, Negishi M, Akuzawa M, Hayashi R, Shimomura Y, Kobayashi I (2009) A proposal of combined evaluation of waist circumference and BMI for the diagnosis of metabolic syndrome. Endocr J 56(9):1079–1082
21. Hara K, Matsushita Y, Horikoshi M, Yoshiike N, Yokoyama T, Tanaka H, Kadowaki T (2006) A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care 29(5):1123–1124. doi:10.2337/diacare.2951123
22. Oka R, Kobayashi J, Yagi K, Tanii H, Miyamoto S, Asano A, Hagishita T, Mori M, Moriuchi T, Kobayashi M, Katsuda S, Kawashiri MA, Nohara A, Takeda Y, Mabuchi H, Yamagishi M (2008) Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract 79(3):474–481. doi:10.1016/j.diabres.2007.10.016
23. Doi Y, Ninomiya T, Hata J, Yonemoto K, Arima H, Kubo M, Tanizaki Y, Iwase M, Iida M, Kiyohara Y (2009) Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study. Stroke 40(4):1187–1194. doi:10.1161/STROKEAHA.108.531319
24. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB, Oh SJ, Park CY, Yoo HJ (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 75(1):72–80. doi:10.1016/j.diabres.2006.04.013
25. Weng X, Liu Y, Ma J, Wang W, Yang G, Caballero B (2007) An urban-rural comparison of the prevalence of the metabolic syndrome in Eastern China. Public Health Nutr 10(2):131–136. doi:10.1017/S1368980007226023
26. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
27. Yamada S, Tsukamoto Y, Irie J (2007) Waist circumference in metabolic syndrome. Lancet 370(9598):1541–1542. doi:10.1016/S0140-6736(07)61656-0
28. Zhang L, Tang ZH, Zeng F, Li Z, Zhou L, Li Y (2015) Clinical risk model assessment for cardiovascular autonomic dysfunction in the general Chinese population. J Endocrinol Invest 38(6):615–622. doi:10.1007/s40618-014-0229-8
29. Arredondo M, Fuentes M, Jorquera D, Candia V, Carrasco E, Leiva E, Mujica V, Hertrampf E, Perez F (2011) Cross-talk between body iron stores and diabetes: iron stores are associated with activity and microsatellite polymorphism of the heme oxygenase and type 2 diabetes. Biol Trace Elem Res 143(2):625–636. doi:10.1007/s12011-010-8895-7
30. Valenti L, Dongiovanni P, Motta BM, Swinkels DW, Bonara P, Rametta R, Burdick L, Frugoni C, Fracanzani AL, Fargion S (2011) Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Arterioscler Throm Vasc 31(3):683–690. doi:10.1161/Atvbaha.110.214858
31. Yegin ZA, Iyidir OT, Demirtas C, Suyani E, Yetkin I, Pasaoglu H, Ilhan C, Sucak GT (2015) The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders. J Endocrinol Invest 38(3):333–338. doi:10.1007/s40618-014-0174-6
32. La Carrubba S, Antonini-Canterin F, Fabiani I, Colonna P, Pugliese NR, Caso P, Conte L, Benedetto F, Zito C, Citro R, Carerj S, Di Bello V (2016) Prevalence and prognostic impact of metabolic syndrome in asymptomatic (stage A and B heart failure) Patients. Metab Syndr Relat Disord 14(3):187–194. doi:10.1089/met.2015.0143
33. Reaven GM (2011) The metabolic syndrome: time to get off the merry-go-round? J Intern Med 269(2):127–136. doi:10.1111/j.1365-2796.2010.02325.x
34. Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, Kullo IJ, Sovio U, Mathias RA, Sun YV, Franceschini N, Absher D, Li G, Zhang Q, Feitosa MF, Glazer NL, Haritunians T, Hartikainen AL, Knowles JW, North KE, Iribarren C, Kral B, Yanek L, O’Reilly PF, McCarthy MI, Jaquish C, Couper DJ, Chakravarti A, Psaty BM, Becker LC, Province MA, Boerwinkle E, Quertermous T, Palotie L, Jarvelin MR, Becker DM, Kardia SL, Rotter JI, Chen YD, Borecki IB (2011) A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes 60(4):1329–1339. doi:10.2337/db10-1011
35. D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286(2):180–187
36. Eichler K, Puhan MA, Steurer J, Bachmann LM (2007) Prediction of first coronary events with the Framingham score: a systematic review. Am Heart J 153(5):722–731. doi:10.1016/j.ahj.2007.02.027
37. Liu J, Hong Y, D’Agostino RB Sr, Wu Z, Wang W, Sun J, Wilson PW, Kannel WB, Zhao D (2004) Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291(21):2591–2599. doi:10.1001/jama.291.21.2591